1IA
SRTA

1620 Investment Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

1620 Investment Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-600
Closed -$3.04K – 651
2025
Q3 		$3.04K Sell
600
-3,806
-86% -$16.8K ﹤0.01% 554
2025
Q2 		$17.8K Hold
4,406
– – 0.01% 410
2025
Q1 		$12K Sell
4,406
-11,280
-72% -$40.5K 0.01% 423
2024
Q4 		$66.7K Buy
15,686
+725
+5% +$2.76K 0.05% 270
2024
Q3 		$44K Buy
14,961
+600
+4% +$1.91K 0.03% 317
2024
Q2 		$50K Buy
+14,361
New +$47.9K 0.04% 296

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

1620 Investment Advisors's SRTA Position: Q4 2025 in Review

1620 Investment Advisors sold out of Strata Critical Medical Inc (SRTA) in Q4 2025, closing a stake of 600 shares — an estimated $3.04K sold.

1620 Investment Advisors first reported a position in SRTA in Q2 2024 and held it in 6 quarters. The position peaked at $66.7K in Q4 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

  • 1620 Investment Advisors reported no remaining Strata Critical Medical Inc position as of Q4 2025 after selling out during the quarter.
  • 1620 Investment Advisors sold 600 Strata Critical Medical Inc shares in Q4 2025, an estimated $3.04K.
  • 1620 Investment Advisors first reported a position in Strata Critical Medical Inc in Q2 2024 and held it in 6 quarters.
  • 1620 Investment Advisors's Strata Critical Medical Inc position peaked at $66.7K in Q4 2024.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on 1620 Investment Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.